Psoriasis and Alcohol: 4 Reasons to Drink Less

If you have psoriasis, you’ve likely experienced itchy, scaly, discolored patches on your skin that can be annoying and uncomfortable. Psoriasis symptoms can disrupt sleep, and the condition is linked with psoriatic arthritis, which can cause pain and joint stiffness.
Because of its symptoms, psoriasis can impact how you feel not only physically but also emotionally. Research suggests this challenge has led many people with the chronic autoimmune disorder to turn to alcohol.
“Does alcohol make psoriasis worse, or does psoriasis make people consume more alcohol? It’s much easier to demonstrate the latter than the former,” Dr. Lebwohl adds.
“Studies to date have been mixed, but it’s been observed by many dermatologists who treat psoriasis that people with the condition become fairly ill after binge drinking, and part of that is that their psoriasis symptoms worsen,” Lebwohl notes.
In addition, many people with psoriasis also have other health problems — from overweight or obesity to high blood pressure or heart disease — and “drinking alcohol doesn’t make any of those things better,” he adds.
Here are four reasons to limit alcohol consumption if you have psoriasis.
Increased Severity of Symptoms
Although the exact cause of psoriasis remains a mystery, what is known is that the condition involves problems with the immune system and inflammation.
Alcohol affects the function of brain chemicals called neurotransmitters, which impact your behavior and body’s responses, including the immune response.
Meanwhile, recent studies have shown that alcohol may negatively impact the skin barrier, the outermost layer of the skin that functions like a brick wall around the inner layers, preventing moisture from escaping and allergens and viruses from entering.
This could worsen the symptoms of psoriasis, research suggests.
Impaired Effectiveness of Treatments
Alcohol may also limit the effectiveness of certain psoriasis treatments and reduce a person’s adherence to their treatment regimen.
“[Biologics] are the newer and better drugs we have to treat psoriasis,” Lebwohl says.
Part of the reason for this is that people with psoriasis who drink are less likely to adhere to their treatment as prescribed.
Raised Risk of Comorbidities
Comorbidities are medical conditions that coexist with another diagnosis and may affect your health and treatment as a result.
Because of psoriasis’s effect on the immune system, people who have it are at an increased risk for certain comorbidities.
Here are the most common comorbidities associated with psoriasis and their potential relationship with alcohol consumption.
“People with psoriasis tend to be overweight or obese, which means their lipid levels tend to be higher,” Lebwohl says. “That’s why they are at higher risk for fatty liver disease.”
Lipids are organic compounds in the body that include fats and cholesterols.
“By themselves, these drugs are no more harmful for the liver than many others we use all the time,” Lebwohl says.
But some drugs, including methotrexate, can lead to hepatic fibrosis when used in combination with alcohol.
This could lead to serious health complications, including cirrhosis.
Possible Increase in Mental Health Issues
Numerous studies have shown that people with psoriasis often have depression, and a significant percentage have anxiety, sometimes along with depression. Depression and anxiety are often related and are themselves comorbidities for each other.
If you’re concerned that your alcohol intake is affecting your mood, your psoriasis, or any other part of your life negatively, talk to your doctor about alcohol use disorder treatments. Options include therapy programs, support groups, medication, and, often, a combination of these.
The Takeaway
- If you have psoriasis, cutting back on alcohol can benefit your skin and your overall health.
- Alcohol can interact with some commonly used psoriasis treatments and lower the chances you’ll follow your treatment regimen.
- Alcohol raises the risk of heart and liver disease and may raise your risk of psoriatic arthritis.

Susan Bard, MD
Medical Reviewer
Susan Bard, MD, is a clinical instructor in the department of dermatology at Weill Cornell Medicine and an adjunct clinical instructor in the department of dermatology at Mount Sinai in New York City. Her professional interests include Mohs micrographic surgery, cosmetic and laser procedures, and immunodermatology.
She is a procedural dermatologist with the American Board of Dermatology and a fellow of the American College of Mohs Surgery.
Dr. Bard has written numerous book chapters and articles for many prominent peer-reviewed journals, and authored the textbook The Laser Treatment of Vascular Lesions.

Brian P. Dunleavy
Author
Brian P. Dunleavy is a writer and editor with more than 25 years of experience covering issues related to health and medicine for both consumer and professional audiences. As a journalist, his work has focused on new research in the treatment of infectious diseases, neurological disorders (including multiple sclerosis and Alzheimer's disease), and pain management. His work has appeared in ADDitude, Consumer Reports, Health, Pain Medicine News, and Clinical Oncology News.
Dunleavy is the former editor of the infectious disease special edition at ContagionLive.com. He is also an experienced sports reporter who has covered the NFL, MLB, NBA, NHL, and professional soccer for a number of publications. He is based in New York City.
- Michalski P, Palazzo-Michalska V, Buda P, et al. A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review. Advances in Dermatology and Allergology. July 5, 2023.
- Potestio L et al. Risk Factors for Psoriasis Flares: A Narrative Review. Psoriasis: Targets and Therapy. March 2024.
- Bandyopadhyay A et al. Proceedings of the 6th IFPA WPPA Conference. Psychodermatology and Psoriasis. June 30, 2023.
- Psoriatic Disease and the Immune System. National Psoriasis Foundation. November 1, 2023.
- Svanström C et al. Psoriasis and Alcohol. Psoriasis: Targets and Therapy. August 21, 2019.
- Iskandar IYK et al. Alcohol Misuse Is Associated With Poor Response to Systemic Therapies for Psoriasis: Findings From a Prospective Multicentre Cohort Study. British Journal of Dermatology. November 2021.
- Zorlu O et al. Treatment Predictors of Drug Survival of Biologic Therapies in Psoriasis Patients. Journal of Dermatological Treatment. February 2022.
- Szentkereszty-Kovács Z et al. Alcohol in Psoriasis — From Bench to Bedside. International Journal of Molecular Sciences. May 7, 2021.
- About Psoriatic Arthritis. National Psoriasis Foundation. February 16, 2024.
- Green A et al. Modifiable Risk Factors and the Development of Psoriatic Arthritis in People With Psoriasis. British Journal of Dermatology. March 2020.
- Piano MR. Alcohol’s Effects on the Cardiovascular System. Alcohol Research: Current Reviews. 2017.
- Bellinato F et al. Risk of Non-Alcoholic Fatty Liver Disease in Patients With Chronic Plaque Psoriasis: An Updated Systematic Review and Meta-Analysis of Observational Studies. Journal of Endocrinological Investigation. 2022.
- Kearney N et al. Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene. American Journal of Clinical Dermatology. November 2022.
- Mastorino L et al. Alcohol Abuse and Discretionary Habits in Psoriatic Patients: Impact on IL-17 and IL-23 Inhibitors Response. JDDG. July 22, 2024.
- Henderson AD et al. Common mental health disorders in adults with inflammatory skin conditions: Nationwide population-based matched cohort studies in the UK. BMC Medicine. August 4, 2023.
- Mathur A et al. Anxiety, depression and harmful use of alcohol in severe chronic plaque psoriasis: A cross-sectional study. Medical Journal, Armed Forces India. February 19, 2021.
- Mental Health Issues: Alcohol Use Disorder and Common Co-occurring Conditions. National Institute on Alcohol Abuse and Alcoholism. January 1, 2024.
- Anxiety and Alcohol: Does Drinking Worsen Symptoms? Cleveland Clinic. September 16, 2022.
- Nunes EV. Alcohol and the Etiology of Depression. American Journal of Psychiatry. March 1, 2023.